Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
04/1991
04/10/1991EP0421829A1 Benzopyranone-beta-D-thioxylosides, method for their preparation and their use
04/10/1991EP0421508A2 Sulphated glycosaminoglycuronan with antithrombotic activity
04/10/1991EP0421367A1 Anticoagulant peptides
04/10/1991EP0421366A1 Radiolabeled anticoagulant peptides
04/10/1991EP0420930A1 Method of synthesis and novel compounds for pharmaceutical uses
04/10/1991CN1050544A Benzopyranone-beta-d-thioxylosides, their method of preparation and their use in therapy
04/09/1991US5006540 Substituted 3-aminosydnonimines, processes for their preparation and their use
04/09/1991US5006539 Thromborane inhibitor
04/09/1991CA1282727C Chemorepellant compound
04/09/1991CA1282694C Agent comprising a plasmin inhibitor and a plasminogen activator for the treatment of thromboses
04/06/1991WO1991004667A1 Use of liposomes as carriers for metalloporphyrins
04/06/1991CA2042576A1 Use of liposomes as carriers for metalloporphyrins
04/05/1991CA2026713A1 Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders
04/04/1991WO1991004974A1 2-bicyclo-benzimidazoles, process for their production and drugs containing said compounds
04/04/1991WO1991004247A1 Chimeric amino acids and peptides containing these analogues
04/04/1991WO1991004246A1 Method for preparing amino acid derivatives and therapeutical applications of same
04/04/1991WO1991002798A3 T-pa mutant gk1l
04/04/1991WO1991001744A3 Uses of interleukin-4 and method for purifying it
04/04/1991DE3931839A1 Neue proteine und ihre herstellung New proteins and their production
04/04/1991CA2066690A1 2-bicyclobenzimidazoles, processes for their preparation and medicaments containing these compounds
04/04/1991CA2026377A1 Radiolabeled anticoagulant peptides
04/03/1991EP0420833A1 Method of increasing specific activity of t-PA
04/03/1991EP0420368A1 Mixture having an anti-thrombotic activity
04/03/1991EP0419878A1 Aprotinin variants and a recombinant method for the microbial preparation of these variants in homogeneously processed form
04/03/1991EP0393190A4 Copolymers of vinyl alcohol with vinyl acetate, cross-linked by glutaric dialdehyde, method of obtaining them and a phramaceutical preparation based thereon
04/03/1991CN1050321A Thrombolytic composition containing tissue type plasminogen activator or derivative thereof
04/02/1991US5004752 Hypotensive agents, antiulcer, antisecretory agents
04/02/1991US5004750 Benzofuran and benzothoiphene derivatives, of tetrazole and anti-hyperuricemia use thereof
04/02/1991US5004681 Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
04/02/1991US5004609 Fibrinophilic urokinase complex
03/1991
03/30/1991WO1991004746A1 Anti-thrombotic peptides and pseudopeptides
03/30/1991CA2066047A1 Anti-thrombotic peptides and pseudopeptides
03/29/1991CA2026404A1 Method of increasing specific activity of t-pa
03/28/1991DE3936594A1 (gamma)-glutamyl-transferasen zur behandlung von krankheiten (Gamma) glutamyl-transferases for treating diseases
03/27/1991EP0419411A2 Additional alkanophenones
03/27/1991EP0419410A2 Alkanophenones
03/27/1991EP0419394A1 Non-digoxin-like Na+,K+-ATPase inhibitory factor
03/27/1991EP0419327A1 Amino acid derivatives, method for their preparation and their therapeutic application
03/27/1991EP0419252A1 Thrombolytic composition containing tissue type plasminogen activator or derivative thereof
03/27/1991EP0419099A1 Proteins having anticoagulant properties
03/27/1991EP0418316A1 Platelet-specific chimeric immunoglobulin
03/27/1991EP0418233A1 Cysteine proteinase inhibitor
03/27/1991CN1050198A Peptidase and isomerase inhibitors
03/26/1991WO1991004029A1 Orally administered porphyrins to control intestinal iron absorption
03/26/1991US5003098 Administering a Myo-Inositol Triphosphate
03/26/1991US5002972 Compound and composition of substituted hexenoic acid derivatives useful for treating thromboxane A2 mediated diseases
03/26/1991CA1282008C Rapid acting intravenous emulsion of omega-3 fatty acid esters
03/24/1991WO1991004275A1 New proteins suitable for combating disease and for protecting grazing cattle from ticks
03/24/1991CA2054190A1 Proteins suitable for combating disease and for protecting grazing cattle from ticks
03/21/1991WO1991003233A1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
03/20/1991EP0417790A2 S-triazolo[3,4-i]purine derivatives
03/20/1991EP0417760A2 Phenylalkanoyl substituted imidazo[4,5-c] pyridines
03/20/1991EP0417721A2 Novel peptidase and isomerase inhibitors
03/20/1991EP0417449A1 Arylpyrazole derivatives as platelet aggregation inhibitors
03/20/1991EP0417104A1 Perfluorochemical emulsion with stabilized vesicles
03/20/1991EP0341264A4 Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction)
03/20/1991CA2025471A1 Additional further novel aklanophenones
03/20/1991CA2025470A1 Further novel alkanophenones
03/19/1991CA1281651C Water soluble polyvinyl lactam-drug complexes
03/19/1991CA1281647C Compositions and methods for the treatment of bleeding disorders
03/16/1991WO1991004046A1 Gamma glutamyl transferases for treating diseases
03/16/1991CA2065157A1 Gamma glutamyl transferases for treating diseases
03/14/1991CA2025202A1 Phenylalkanoyl substituted imidazo {4,5-c} pyridines
03/13/1991EP0416604A2 PAF-antagonists for the preparation of a medicament, useful for the treatment of heart diseases, caused by diminished beta-receptor-stimulation
03/13/1991EP0416064A1 20-alkyl-13,14,18,18,19,19-hexadehydro-3-oxa-isocarbacycline derivatives and their pharmaceutical use
03/13/1991EP0371105A4 Antithrombogenic and antibiotic compositions and methods of preparation thereof
03/13/1991EP0233291B1 2-arylbenzothiazine derivatives
03/13/1991CN1049865A Plasminogen activator complex of pure prourokinase covalently bound by disulfide bridge to human serum albumin
03/12/1991US4999363 Tricyclic compounds
03/12/1991US4999345 Sulfonamide derivatives and drugs obtained therefrom
03/12/1991US4999194 Two-chain urokinase plasminogen activators for treatment of thrombotic disease
03/12/1991US4999188 Methods for embolization of blood vessels
03/12/1991CA2024661A1 Peptidase and isomerase inhibitors
03/12/1991CA1281324C Lipid derivatives, their production and use
03/08/1991CA2024697A1 Protein having anticoagulant properties
03/08/1991CA2024630A1 Paf-antagonists for the preparation of a pharmaceutical composition suitable for treating heart diseases caused by reduced stimulation of .beta.-receptors
03/07/1991WO1991002798A2 t-PA MUTANT GK1L
03/07/1991WO1991002754A1 Fusion proteins comprising gm-csf and il-3
03/07/1991WO1991002753A1 Anticoagulant protein
03/07/1991WO1991002751A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs
03/07/1991DE4019062A1 Stabilising blood substitute emulsions contg. per:fluoro-hydrocarbon
03/06/1991EP0415456A2 Xanthine compounds
03/06/1991EP0415263A2 Stabilisation of perfluorocarbon emulsions and perfluorinated heterocyclic compounds usable as emulsion stabilising additives
03/06/1991EP0414815A1 Blood substitute
03/06/1991EP0190356B1 Novel amidine compounds
03/05/1991US4997847 Biologically active compounds
03/05/1991US4997843 Platelet activating factor, anticoagulants
03/05/1991US4997815 Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin
03/01/1991CA2023435A1 Non-digoxin-like na+, k+-atpase inhibitory factor
02/1991
02/26/1991US4996347 Anticoagulant
02/26/1991US4996050 Single chain pro-urokinase and plasminogin
02/21/1991WO1991002063A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof
02/21/1991WO1991001744A2 Uses of interleukin-4 and method for purifying it
02/21/1991WO1991001724A1 Renal-selective prodrugs for the treatment of hypertension
02/21/1991WO1991000281A3 Fused-ring aryl substituted imidazoles
02/21/1991CA2064753A1 Uses of interleukin-4 and method for purifying it
02/20/1991EP0413433A1 Isoindolyl-imidazole-derivatives and pharmaceutical compositions
02/20/1991EP0413383A1 Mutants of human interleukin-3
02/20/1991EP0413248A1 Substances with heparin-like structure and their method of production
02/20/1991EP0413056A1 Method for reducing astringency and bitterness of tannic acid
1 ... 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 ... 671